Russell Investments Group
BNTC icon

Russell Investments Group’s Benitec Biopharma BNTC Stock Holding History

Russell Investments Group’s Portfolio BNTC Stock Details BNTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.24M Buy
116,190
+109,972
+1,769% +$1.27M ﹤0.01% 2111
2025
Q4 		$83.8K Buy
6,218
+603
+11% +$8.34K ﹤0.01% 3113
2025
Q3 		$78.8K Buy
+5,615
New +$71.7K ﹤0.01% 3112

Other funds holding BNTC

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
IAM
Infinitum Asset Management Fort Lauderdale, Florida $801M AUM 8.83% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Russell Investments Group's BNTC Position: Q1 2026 in Review

Russell Investments Group increased its Benitec Biopharma (BNTC) stake by 1,769% in Q1 2026, buying an estimated $1.27M and bringing the position to 116,190 shares worth $1.24M. The position accounts for ﹤0.01% of the portfolio, ranked #2111.

Russell Investments Group first reported a position in BNTC in Q3 2025 and has held it in 3 quarters since. 88 funds tracked by Wall St. Rank hold BNTC as of Q1 2026.

  • Russell Investments Group held 116,190 shares of Benitec Biopharma worth $1.24M as of Q1 2026.
  • Russell Investments Group bought 109,972 Benitec Biopharma shares in Q1 2026, an estimated $1.27M.
  • Benitec Biopharma made up ﹤0.01% of Russell Investments Group's portfolio in Q1 2026, its #2111 holding.
  • Russell Investments Group first reported a position in Benitec Biopharma in Q3 2025 and has held it in 3 quarters since.
  • 88 funds tracked by Wall St. Rank held Benitec Biopharma as of Q1 2026.

Based on Russell Investments Group's 13F filing for Q1 2026, filed 8 May 2026.